Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-22-016867
Filing Date
2022-08-11
Accepted
2022-08-11 16:09:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a_-_notice_and_acc.htm DEFA14A 36890
2 GRAPHIC img39799937_0.jpg GRAPHIC 503272
3 GRAPHIC img39799937_1.jpg GRAPHIC 536119
  Complete submission text file 0000950170-22-016867.txt   1469072
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40631 | Film No.: 221155801
SIC: 2836 Biological Products, (No Diagnostic Substances)